In the last five years of life, total health care spending for people with dementia healthcare costs was more than a quarter-million dollars per person, some 57 percent greater than costs associated with death from other diseases, including cancer and heart…
Some Stem Cells Are Rejected, Some Aren’t, Says iPSC Work
Embryonic stem (ES) cell-like stem cells made from adult cells—and morphed into eye cells—are not rejected by the immune system, according to “humanized mouse” data in Cell Stem Cell. The Cell Stem Cell paper also offered a different kind of eye-opener…
N.J. Researchers Closing in on Alzheimer’s, Parkinson’s Tests
Alzheimer’s is feared for its quiet progress, giving only overlooked warning signs until it’s too late to use the few interventions available to slow it down.But a new test under development at a New Jersey medical laboratory promises to diagnose the…
New Ebola Vaccine Has ‘100 Percent’ Effectiveness In Early Results
In a development that could change the way the deadly Ebola disease is fought, researchers have announced promising results of a new vaccine’s trial in Guinea, one of several countries affected by a historic outbreak in West Africa. “The estimated vaccine…
Phase II-III Services- South America
FOMAT Medical is a specialist in Phase 2, 3 & Phase 4 clinical trials in South America. FOMAT is a Site Management Organization providing services that specialize in the development and management of clinical trials. We meet expectations by concentrating on…
Scientists Announce Major Breakthrough Against Rare Kidney Disease
Scientists at The University of Manchester and Central Manchester University Hospitals NHS Foundation Trust have made a significant breakthrough in the fight against Membranous Nephropathy (MN) – a rare kidney disease research which can lead to kidney failure. Their research was…
New Approaches to Virtual Screening
Ivan Solt, Anna Tomin, Krisztian Niesz, ChemAxon Ltd. Virtual screening (VS) aims to reduce the enormous virtual space of chemical compounds (a practical virtual library might comprise ~1015 molecules) to a more manageable number for further synthesis and screening against biological…
Novartis’ Lung Cancer Drug Gets European Approval
Novartis announced that the European Commission has approved Zykadia (ceritinib) to treat adult patients with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC) previously treated with crizotinib. The approval of Zykadia in the European Union (EU) provides patients with…
Potential for a More Personalized Approach to Uterine (Womb) Cancer
Manchester doctors have helped show that high-risk womb cancer patients can be genetically profiled to allow them to receive more appropriate treatment. Traditionally, patients with endometrial cancer – cancer of the womb lining – have their disease risk classified using a…
NIH study solves ovarian cell mystery, shedding new light on reproductive disorders
Scientists at the National Institutes of Health have solved a long-standing mystery about the origin of one of the cell types that make up the ovary. The team also discovered how ovarian cells share information during development of an ovarian follicle,…